Richard D. Moore
Impact in
- Virology top 0.05%
- HIV Research and Treatment
- Infectious Diseases top 0.01%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
- Virology 166
- HIV Research and Treatment 166
-
- HIV/AIDS Research and Interventions 339
- HIV/AIDS drug development and treatment 158
- Co-authors
- Richard E. ChaissonKelly A. GeboJeanne KerulyGregory M. LucasPaul S. LietmanCraig R. SmithMary Catherine BeachJoel E. Gallant
- Journals
- AIDS (78 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (72 papers)Clinical Infectious Diseases (52 papers)AIDS and Behavior (23 papers)PLoS ONE (20 papers)
- Partner nations
- United StatesCanadaPuerto Rico
In The Last Decade
Richard D. Moore
612 papers receiving 29.3k citations
Hit Papers
Peers
Comparison fields: 5 of 200
- Virology 6.4k
- Infectious Diseases 16.3k
- Emergency Medicine 5.2k
- Epidemiology 12.3k
- Hepatology 2.0k
Countries citing papers authored by Richard D. Moore
This map shows the geographic impact of Richard D. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Moore more than expected).
Fields of papers citing papers by Richard D. Moore
This network shows the impact of papers produced by Richard D. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Moore. The network helps show where Richard D. Moore may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard D. Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 5 | |
| 6 | 2021 | 9 | |
| 7 | 2021 | 1 | |
| 8 | 2021 | 7 | |
| 9 | 2019 | 13 | |
| 10 | 2019 | 7 | |
| 11 | 2018 | 13 | |
| 12 | 2018 | 9 | |
| 13 | 2018 | 5 | |
| 14 | Clinic-Based Treatment of Opioid-Dependent HIV-Infected Patients Versus Referral to an Opioid Treatment Program | 2010 | 5 |
| 15 | 2006 | 201 | |
| 16 | 2002 | 28 | |
| 17 | 1999 | 2 | |
| 18 | Zidovudine therapy and health resource utilization in AIDS. | 1994 | 21 |
| 19 | 1991 | 63 | |
| 20 | Effect of freund's adjuvant on sarcoma-180 in mice. | 1961 | 1 |
About Richard D. Moore
Richard D. Moore is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Epidemiology and Hepatology, having authored 635 papers that have together received 30.6k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (339 papers), HIV Research and Treatment (166 papers), HIV/AIDS drug development and treatment (158 papers), HIV-related health complications and treatments (141 papers), HIV, Drug Use, Sexual Risk (128 papers), Pneumocystis jirovecii pneumonia detection and treatment (59 papers), Hepatitis C virus research (41 papers) and Viral-associated cancers and disorders (35 papers). The work is most often cited by research in Virology (6.4k citations), Infectious Diseases (16.3k citations), Emergency Medicine (5.2k citations), Epidemiology (12.3k citations) and Hepatology (2.0k citations). Richard D. Moore has collaborated with scholars based in United States, Canada and Puerto Rico. Frequent co-authors include Richard E. Chaisson, Kelly A. Gebo, Jeanne Keruly, Gregory M. Lucas, Paul S. Lietman, Craig R. Smith, Mary Catherine Beach, Joel E. Gallant, Bryan Lau and Geetanjali Chander. Their work appears in journals such as AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, Clinical Infectious Diseases, AIDS and Behavior and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.